UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000027952
Receipt No. R000032021
Official scientific title of the study Research on the evaluation of adenovirus antigen detection kit
Date of disclosure of the study information 2017/06/28
Last modified on 2017/06/27 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Research on the evaluation of adenovirus antigen detection kit
Title of the study (Brief title) Evaluation of adenovirus detection kit
Region
Japan

Condition
Condition epidemic keratoconjunctivitis
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of the efficacy and safety of a novel adenovirus antigen detection kit on epidemic keratoconjunctivitis
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparing the sensitivity and specificity of novel and current kits on adenovirus PCR positivity
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Viral sampling by conjunctival scrapings
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Cases with acute conjunctivitis diagnosed clinically as epidemic keratoconjunctivitis
Key exclusion criteria Cases who reject to join this clinical research
Target sample size 50

Research contact person
Name of lead principal investigator Eiichi Uchio
Organization Fukuoka University School of Medicine
Division name Department of Ophthalmology
Address 7-45-1 Nanakuma, Jonan, Fukuoka, Japan
TEL 0928011011
Email euchio@fukuoka-u.ac.jp

Public contact
Name of contact person Eiko Matsuda
Organization Wako Pure Chemical Industries, Ltd.
Division name Division of Clinical Test Development
Address 3-1-2 Doshomachi, Chuo, Osaka
TEL 0662032392
Homepage URL
Email matsuda.eiko@wako-chem.co.jp

Sponsor
Institute Fukuoka University
Institute
Department

Funding Source
Organization Wako Pure Chemical Industries. Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福岡大学病院(福岡県),小沢眼科医院(福岡県),こにし眼科医院(福岡県)

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 28 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 07 Month 12 Day
Anticipated trial start date
2017 Year 07 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 06 Month 27 Day
Last modified on
2017 Year 06 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032021